StockNews.com assumed coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a report published on Wednesday morning. The brokerage issued a hold rating on the software maker’s stock.
Separately, Stephens lifted their price objective on Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a report on Friday, January 31st.
View Our Latest Research Report on Veradigm
Veradigm Stock Performance
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Stories
- Five stocks we like better than Veradigm
- What is MarketRank™? How to Use it
- Homebuilders in Freefall: Bargain Opportunity or Falling Knife?
- What Are Dividend Achievers? An Introduction
- The 3 Most Talked About Investments on WallStreetBets Right Now
- What is the Dow Jones Industrial Average (DJIA)?
- Analyst Targets Signal More Growth in CrowdStrike Stock
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
